KSHN-001126

N/A

Report date: 2026/02/20 20:02:00

Base Information

Drug NameKSHN-001126
Drug Alias NameProdrugs of fulvestrant(KSHN-001126)KSHN-001126
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors antagonistsEstrogen receptors degraders
TargetsEstrogen receptors
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKashiv BioSciences LLC
China Registration ClassN/A

Develop Information

Active CompaniesAmneal Pharmaceuticals LlcKashiv BioSciences LLC
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A